Zobrazeno 1 - 10
of 1 362
pro vyhledávání: '"Barrett TD"'
Autor:
Jensen MP; Department of Rehabilitation Medicine, University of Washington, Seattle, WA 98195, USA., Barrett TD; Department of Rehabilitation Medicine, University of Washington, Seattle, WA 98195, USA.
Publikováno v:
Brain sciences [Brain Sci] 2024 May 30; Vol. 14 (6). Date of Electronic Publication: 2024 May 30.
Autor:
Ganz T; Department of Medicine and Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA. Tganz@mednet.ucla.edu., Nemeth E; Department of Medicine, University of California, Los Angeles, CA, 90095, USA., Rivella S; Department of Pediatrics, Division of Hematology, Children's Hospital of Philadelphia (CHOP), 3401 Civic Center Boulevard, Philadelphia, PA, 19104, USA.; Cell and Molecular Biology Graduate Group (CAMB), University of Pennsylvania, Abramson Research Center, 3615 Civic Center Boulevard, Room 316B, Philadelphia, PA, 19104, USA., Goldberg P; Prilenia Therapeutics, Herzliya, Israel.; Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Dibble AR; Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., McCaleb ML; Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Guo S; Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Monia BP; Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Barrett TD; Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA. TBarrett@ionisph.com.
Publikováno v:
Advances in therapy [Adv Ther] 2023 Apr; Vol. 40 (4), pp. 1317-1333. Date of Electronic Publication: 2023 Jan 23.
Autor:
Villegas-Morcillo A; InstaDeep, London W2 1AY, UK.; Department of Signal Theory, Telematics and Communications, University of Granada, Granada 18071, Spain., Robinson L; InstaDeep, London W2 1AY, UK., Flajolet A; InstaDeep, London W2 1AY, UK., Barrett TD; InstaDeep, London W2 1AY, UK.
Publikováno v:
Bioinformatics (Oxford, England) [Bioinformatics] 2023 Jan 01; Vol. 39 (1).
Autor:
Rådholm, K, Figtree, G, Perkovic, V, Solomon, SD, Mahaffey, KW, De Zeeuw, D, Fulcher, G, Barrett, TD, Shaw, W, Desai, M, Matthews, DR, Neal, B
BACKGROUND : Canagliflozin is a sodium glucose cotransporter 2 inhibitor that reduces the risk of cardiovascular events. We report the effects on heart failure and cardiovascular death overall, in those with and without a baseline history of heart fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::5dec0c674df15d90a8144e0a504c33ec
http://hdl.handle.net/10044/1/59713
http://hdl.handle.net/10044/1/59713
Autor:
Barrett, TD1, Lagaud, G2, Wagaman, P3, Freedman, JM1, Yan, W1, Andries, L4, Rizzolio, MC1, Morton, MF1, Shankley, NP1
Publikováno v:
British Journal of Pharmacology. Jul2012, Vol. 166 Issue 5, p1684-1693. 10p.
Autor:
Cione, Ferdinando1 (AUTHOR) fcione@unisa.it, De Bernardo, Maddalena1 (AUTHOR) mdebernardo@unisa.it, Gioia, Marco1 (AUTHOR) nrosa@unisa.it, Oliviero, Marianunzia1 (AUTHOR), Santoro, Andrea Giuseppe1 (AUTHOR), Caputo, Alessandro1 (AUTHOR), Capasso, Luigi2 (AUTHOR), Pagliarulo, Sergio1 (AUTHOR), Rosa, Nicola1 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Apr2023, Vol. 12 Issue 8, p2890. 16p.
Autor:
Park, Hansol1 (AUTHOR), Yoo, Young-Sik2 (AUTHOR), Shin, Eunhae1 (AUTHOR), Song, Won Seok1 (AUTHOR), Won, Yeokyoung1 (AUTHOR), Chung, Tae-Young1,3 (AUTHOR), Lim, Dong Hui1,4 (AUTHOR) donghui.lim@samsung.com
Publikováno v:
PLoS ONE. 12/31/2024, Vol. 19 Issue 12, p1-10. 10p.
Autor:
Barret, Maximilien1,2 (AUTHOR) maxbarret5744@yahoo.fr
Publikováno v:
Hépato-Gastro & Oncologie Digestive. 2024 Supplement 6, Vol. 31, p29-34. 6p.
Publikováno v:
Health Expectations. Dec2024, Vol. 27 Issue 6, p1-95. 95p.
Autor:
Sayaf, Abrar Mohammad1 (AUTHOR), Kousar, Kafila2 (AUTHOR), Suleman, Muhammad3 (AUTHOR), Albekairi, Norah A.4 (AUTHOR), Alshammari, AbdulRahman3 (AUTHOR), Mohammad, Anwar5 (AUTHOR), Khan, Abbas6,7 (AUTHOR) abbas.khan@qu.edu.qa, Agouni, Abdelali6 (AUTHOR) aagouni@qu.edu.qa, Yeoh, Kar Kheng1 (AUTHOR) kkyeoh@usm.my
Publikováno v:
BMC Chemistry. 11/26/2024, Vol. 18 Issue 1, p1-18. 18p.